Autologous iPSC-Derived Dopamine Neuron Transplantation for Parkinson's Disease
Autologous iPSC-Derived Dopamine Neuron Transplantation for Parkinson's Disease
Enrolling by invitation · NCT06422208 · Registry updated 2026-09-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Autologous iPSC-Derived Dopamine Neuron Transplantation for Parkinson's Disease | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Enrolling by invitation | Phase 1 | 2026-09-15 | NCT06422208 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Institute of Neurological Disorders and Stroke (NINDS) | 370 |
| Oryon Cell Therapies | 1 |
| Penelope J. Hallett, Ph.D. | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Brigham & Women's Hospital | Boston | United States | 3 |